ArticleBMC infectious diseases2024

Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain.

Jorge Mestre-Ferrándiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.